EarningsPreliminary Q4 results were slightly below expectations, which may have caused some concern among investors.
Growth OutlookCommentary from a recent conference call suggested that the 2025 outlook for the core Tempus business could be guided below expectations next quarter.
ValuationThe stock is up about 100% since its debut, but valuation now sits well above key peers, with shares sitting at 12.5 times '25 sales compared to NTRA at 9.4 and GH at 4.6.